Responses
Intensive care
Protocol
Rationale and design of a prospective, multicentre, randomised, conventional treatment-controlled, parallel-group trial to evaluate the efficacy and safety of ulinastatin in preventing acute respiratory distress syndrome in high-risk patients
Compose a Response to This Article
Other responses
No responses have been published for this article.